CRISPR-based Gene Editing Market Report 2024-2030,
Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product...
Gene
Revolutionizing Healthcare: Gene Therapy Products Market
Gene Therapy Products MarketThe Gene Therapy Products Market sector is undergoing significant transformation, with substantial growth and technological advancements expected...
Thalassaemia gene therapy: NICE approves Nobel Prize-winning CRISPR technology for NHS use
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
Six steps healthcare leaders should consider before launching a cell and gene therapy program
Emerging novel cell and gene therapies allow for the possibility of untethering patients from a lifetime of burdensome, costly chronic...
How will CRISPR gene editing change healthcare?
For years, one medical technology has captivated the scientific community: CRISPR. In 2012, Emmanuelle Charpentier, a microbiologist, geneticist and biochemist,...
World’s first CRISPR-based gene therapy approved for sickle cell anaemia
Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the...
CRISPR gene editing: Moving closer to home
Around the turn of the century, microbiologists at Danisco USA Inc. had a problem: The bacteria they used to make...
Could gene therapy cure PWS?
Understanding the relationship between thyroid health and Prader-Willi Syndrome (PWS) can shed light on the intricate connections between hormonal imbalances and genetic...
FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease
CNN — The US Food and Drug Administration approved two gene-based treatments for sickle cell disease Friday, including the first...
